MOREPENLABNSEMorepen Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Thu, 23 Apr · 15:49 IST

Morepen Laboratories Limited has informed the Exchange about execution of loan agreement with Shinhan Bank

New Credit FacilityCredit & Debt View source PDF

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹42.80
prior close
₹42.81
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.7-0.8-1.8+1.3-1.4-2.4-3.2-1.4+1.6-3.2+2.2+21.5+25.7
Up moveDown movePending
AI summary

Morepen Laboratories has availed an unsecured term loan facility of Rs. 30 crore from Shinhan Bank for general business purposes. The loan carries an interest rate of 7.60% (Repo rate 5.25% plus 2.35% spread), with a tenure of 36 months repayable in 10 equal quarterly installments after a 6-month moratorium. The company's total outstanding loan exposure stands at Rs. 182.62 crore excluding this new facility. Mr. Sushil Suri, Promoter, Chairman and Managing Director, has provided personal guarantee for this loan. The transaction is not considered a related party transaction.

Likely market impact

The new debt increases Morepen's total borrowing to over Rs. 212 crore, which raises the company's financial leverage. While the interest rate is market-linked and the loan terms appear standard, shareholders should monitor debt servicing capacity going forward.